Herranz-Ors, Carmen

Dr Carmen Herranz-Ors

Postdoctoral Fellow

Garnett Group
Translational Cancer Genomics

Carmen Herranz-Ors joined the Translational Cancer Genomics group in March 2020 to work in a project related with of colorectal cancer organoids

My Ph.D. was about the study of a rare disease called Lymphangioleiomyomatosis.

Now, I am working on high-throughput drug screenings in colorectal cancer organoid models to find novel therapies (single compounds or combinations) and biomarkers of response.

My timeline

Postdoctoral Fellow at the Wellcome Trust Sanger Institute
Graduated from Universitat Pompeu Fabra, Spain, PhD Biomedicine. Title: "Towards improving lymphangioleiomyomatosis care: a study of biomarkers and therapies"
Graduated from Universitat Pompeu Fabra, Spain, MSc Biomedical Research
Graduated from Universitat Autonoma de Barcelona, Spain, BSc Genetics

Wellcome Sanger Institute

Programmes and Facilities

Programme

Cancer, Ageing and Somatic Mutation

The Cancer, Ageing and Somatic Mutation Programme pioneers data aggregation and informatics innovation, develops high-throughput cellular models of cancer for genome-wide ...